Related Experiment Video
Updated: Jul 4, 2026
10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
What drives success for specialty pharmaceuticals?
Mark Gudiksen1, Edd Fleming, Laura Furstenthal
1McKinsey & Company, 3075A Hansen Way, Palo Alto, California 94304, USA.
Nature Reviews. Drug Discovery
|June 7, 2008
Summary
Specialty pharmaceuticals are gaining importance globally. This analysis identifies key factors driving commercial success and failure in this growing market.
Area of Science:
- Pharmaceutical Sciences
- Market Analysis
- Healthcare Economics
Background:
- Specialty pharmaceuticals represent a rapidly expanding sector within the global pharmaceutical industry.
- Major pharmaceutical firms are increasingly focusing on developing therapies for specialty markets.
- These markets offer significant advantages, including proven commercial histories and reduced infrastructure costs.
Approach:
- This article provides an in-depth analysis of the critical elements influencing commercial outcomes for specialty pharmaceuticals.
- We examine the multifaceted drivers contributing to both the success and failure of these specialized therapies.
Key Points:
- Understanding market dynamics and patient populations is crucial for specialty drug commercialization.
- Effective regulatory strategies and market access pathways are vital for success.
- Post-launch monitoring and adaptation are essential to navigate market challenges.
Conclusions:
- Commercial success in specialty pharmaceuticals hinges on a strategic combination of scientific innovation, market understanding, and adaptive commercialization.
- Failure often results from inadequate market assessment, pricing pressures, or competitive challenges.
More Related Videos
Related Concept Videos
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).